
Join to View Full Profile
813 Shades Creek PkwySte 205Birmingham, AL 35209
Phone+1 205-578-1799
Dr. Flanagan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Katherine Flanagan is a board-certified dermatologist who has practiced medical, pediatric and cosmetic dermatology in Birmingham. Prior to starting her dermatology residency at Saint Louis University, Dr. Flanagan completed an internal medicine residency at UAB and a clinical trials fellowship in the Department of Dermatology at Saint Louis University. She served as Chief Resident at Saint Louis University. Dr. Flanagan feels that her internal medicine background combined with her dermatology training allows her to take an unique and comprehensive approach to her patients.
Education & Training
- SSM Health/Saint Louis University School of MedicineResidency, Dermatology, 2008 - 2011
- Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 2002 - 2005
- University of Alabama Medical CenterResidency, Internal Medicine, 1999 - 2002
- University of Tennessee Health Science Center College of MedicineClass of 1999
Publications & Presentations
PubMed
- 17 citationsThe methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in childrenSyed I. Rahman, Elaine C. Siegfried, Katherine H. Flanagan, Eric S. Armbrecht
Journal of the American Academy of Dermatology. 2014-02-01 - 15 citationsAn open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis.Katherine H Flanagan, Dee Anna Glaser
Journal of Drugs in Dermatology. 2009-05-01 - 16 citationsBotulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.Katherine H Flanagan, Rosemary King, Dee Anna Glaser
Journal of Drugs in Dermatology. 2008-03-01
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: